Editorial: Turning point in myocarditis

Circulation Research

Volumn 105, Issue 5, 2009, Pages 403-405

  Cunningham, Madeleine W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC MYOSIN; COLLAGEN; EPITOPE; HEART ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17; INTERLEUKIN 6; MEMBRANE PROTEIN; PROMININ 1; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG; VIRUS PROTEIN; CD133 ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PTPRC PROTEIN, MOUSE;

ADAPTIVE IMMUNITY; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; AUTOIMMUNE DISEASE; BACTERIUM; BONE MARROW; CARDIOMYOPATHY; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MOTILITY; CELLULAR IMMUNITY; CHLAMYDIA; CHRONIC DISEASE; CONGESTIVE CARDIOMYOPATHY; COXSACKIE VIRUS; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE DURATION; EDITORIAL; ENTEROVIRUS; EXTRACELLULAR MATRIX; FIBROBLAST; HEART EJECTION FRACTION; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HEART VENTRICLE HYPERTROPHY; HUMAN; IMMUNE RESPONSE; IMMUNOADSORPTION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; MEDICAL DECISION MAKING; MUSCLE WEAKNESS; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTOZOON; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION; VIRUS; VIRUS INFECTION; VIRUS MYOCARDITIS; ANIMAL; CELL LINEAGE; CELL TRANSDIFFERENTIATION; DISEASE MODEL; FIBROSIS; IMMUNOLOGY; METABOLISM; MOUSE; NOTE; PATHOLOGY; STEM CELL; TIME;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD45; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINEAGE; CELL TRANSDIFFERENTIATION; COLLAGEN; DISEASE MODELS, ANIMAL; FIBROBLASTS; FIBROSIS; GLYCOPROTEINS; HUMANS; MICE; MYOCARDITIS; MYOCARDIUM; PEPTIDES; SIGNAL TRANSDUCTION; STEM CELLS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 70149101084     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.205195     Document Type: Editorial

References (45)

1. Caforio AL, Goldman JH, Haven AJ, Baig KM, McKenna WJ. Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol. 1996;54:157-163.
2. Brown CA, O'Connell JB. Myocarditis and idiopathic dilated cardiomyopathy. Amer J Med. 1995;99:309-314.
3. Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine. 1999;78:270-283.
4. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18: 619-624.
5. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr, Olsen EG, Schoen FJ. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3-14.
6. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol. 1983;52:1072-1078.
7. Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol. 1982;48: 533-545.
8. Woodruff JF. Viral myocarditis- a review. Am J Pathol. 1980;101: 425-466.
9. Huber SA, Job LP, Woodruff JF. Lysis of infected myofibers by cox-sackievirus B3 immune lymphocytes. Am J Pathol. 1980;98:681-694.
10. Cooper LT Jr. Giant cell myocarditis: diagnosis and treatment. Herz. 2000;25:291-298.
11. Cooper LT Jr, Berry GJ, Shabetai R. Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med. 1997;336:1860-1866.
12. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Gatewood SJ, Njoku DB, Rose NR. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol. 2004;165: 1883-1894.
13. Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJ, Rose NR. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol. 2005;174:261-269.
14. Kania G, Blyszczuk P, Stein S, Valaperti A, Germano D, Dirnhofer S, Hunziker L, Matter CM, Eriksson U. Heart-infiltrating prominin-1-/ CD133- progenitor cells represent the cellular source of transforming growth factor-mediated cardiac fibrosis in experimental autoimmune myocarditis. Circ Res. 2009;105:462-470.
15. Towbin JA, Bowles KR, Bowles NE. Etiologies of cardiomyopathy and heart failure. Nat Med. 1999;5:266-267.
16. Cooper LT, Virmani R, Chapman NM, Frustaci A, Rodeheffer RJ, Cunningham MW, McNamara DM. National Institutes of Health-sponsored workshop on inflammation and immunity in dilated cardiomyopathy. Mayo Clin Proc. 2006;81:199-204.
17. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation. 1992; 85:1734-1742.
18. Cooper LT Jr, Shabetai R. Immunosuppressive therapy for myocarditis. N Engl J Med. 1995;333:1713-1714.
19. Cooper LT, Belohlavek M, Korinek J, Yoshifuku S, Sengupta PP, Burg-staler EA, Winters JL. A pilot study to assess the use of protein A immunoadsorption for chronic dilated cardiomyopathy. J Clin Apheresis. 2007;22:210-1144
20. Burgstaler EA, Cooper LT, Winters JL. Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniques. J Clin Apheresis. 2007;22:224-232.
21. Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 1999;283:1335-1339.
22. Zabriskie JB. Rheumatic fever: the interplay between host, genetics and microbe. Circulation. 1985;71:1077-1086.
23. McManus BM, Chow LH, Wilson JE, Anderson DR, Gulizia JM, Gauntt CJ, Klingel KE, Beisel KW, Kandolf R. Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol. 1993;68:159-169.
24. Bowles NE, Richardson PJ, Olsen EG, Archard LC. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet. 1986;1:1120-1123.
25. Herskowitz A, Wolfgram LJ, Rose NR, Beisel KW. Coxsackievirus B3 murine myocarditis: a pathologic spectrum of myocarditis in genetically defined inbred strains. J Am Coll Cardiol. 1987;9:1311-1319.
26. Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR. Variations in the susceptibility to coxsackievirus B3-ionduced myocarditis among different strains of mice. J Immunol. 1986;136:1846-1852.
27. Abelmann WH. Classification and natural history of primary myocardial disease. Prog Cardiovasc Dis. 1984;27:73-94.
28. Rose NR. Viral damage or 'molecular mimicry'-placing the blame in myocarditis. Nat Med. 2000;6:631-632.
29. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol. 1987;139:3630-3636.
30. Cooper LT. Myocarditis. N Engl J Med. 2009;360:1526-1538.
31. Zhang P, Cox CJ, Alvarez KM, Cunningham MW. Cutting edge: cardiac myosin activates innate immune responses through TLRs. J Immunol. 2009;183:27-31.
32. Mascaro-Blanco A, Alvarez K, Yu X, Lindenfeld J, Olansky L, Lyons T, Duvall D, Heuser JS, Gosmanova A, Rubenstein CJ, Cooper LT, Kem DC, Cunningham MW. Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity. Sep. 2008;41:442-453.
33. Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM. Dendritic cell- induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med. Dec. 2003;9:1484-1490.
34. Smith SC, Allen PM. Myosin-induced acute myocarditis is a T cell mediated disease. J Immunol. 1991;147:2141-2147.
35. Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity. 2004;37:131-145.
36. Kodama M, Matsumoto Y, Fujiwara M, Masani F, Izumi T, Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol. 1991;57:250-262.
37. Kodama M, Hanawa H, Saeki M, Hosono H, Inomata T, Suzuki K, Shibata A. Rat dilated cardiomyopathy after autoimmune giant cell myo-carditis. Circ Res. 1994;75:278-284.
38. Rangachari M, Mauermann N, Marty RR, Dirnhofer S, Kurrer MO, Komnenovic V, Penninger JM, Eriksson U. T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med. 2006;203:2009-2019.
39. Albanesi C, Cavani A, Girolomoni G. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF alpha. J Immunol. 1999;162:494-502.
40. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol. 2007;25:821-852.
41. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT. Interleukin 17-producing CD4- effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol. Nov. 2005;6:1123-1132.
42. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol. 2006;18: 349-356.
43. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol. 2005;6: 1133-1141.
44. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441: 235-238.
45. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, Shimizu J, Takahashi T, Nomura T. Foxp3- CD25-CD4- natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev. 2006;212:8-27.